{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-101333","form_type":"8-K","ticker":"PTPI","cik":"0001815903","company_name":"Petros Pharmaceuticals, Inc.","filed_at":"2024-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.631355+00:00","generated_at":"2026-05-31T03:41:26.175068+00:00","sec_items":["5.08"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Petros Pharmaceuticals sets 2024 annual meeting for Nov 20; shareholder proposals due Sept 29","bullets":["Annual meeting scheduled for November 20, 2024; record date October 14, 2024.","Shareholder proposals under Rule 14a-8 must be received by September 29, 2024.","Director nominations and other business proposals also due September 29, 2024.","Meeting date changed by more than 30 days from 2023 anniversary, triggering new deadlines.","Universal proxy rule compliance notice must be provided by September 29, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-101333","json":"https://secwatch.observer/filing/0001104659-24-101333.json","markdown":"https://secwatch.observer/filing/0001104659-24-101333.md","text":"https://secwatch.observer/filing/0001104659-24-101333.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815903/000110465924101333/0001104659-24-101333-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815903/000110465924101333/tm2424409d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T03:41:26.175068+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}